Purchase Order HHSD2002015M88064P
- Not listed
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
- This is a $114,707.80 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the provision of laboratory supplies. The contract has no set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and laboratory equipment, has a history of providing critical care analyzers, reagents, test kits, and associated supplies and services to various federal agencies, including the...
- This federal contract award, valued at $90,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of a MAGNA PURE 96 INSTRUMENT and does not have a set-aside designation. Roche Diagnostics has previously received prime contract and subcontract awards from various federal agencies,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for ROCHE MAGNA PURE 96 laboratory equipment. The contract has a ceiling value of $90,000.00 and a completion date of September 29, 2022. Roche Diagnostics has experience as a prime contractor and subcontractor providing medical equipment, reagents, and associated products and services to various federal agencies, including the Department of Veterans Affairs,...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $75,000.00 and was awarded on December 5, 2016 with a completion date of November 12, 2020. The award does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers,...
This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies through prime contract awards and subcontracts. This award is associated with Roche's General Services Administration (GSA) Schedule contracts, which allow federal customers to acquire Roche's products and services on an as-needed basis. The contract provides the CDC Pittsburgh facility with access to Roche's portfolio of medical devices and consumables to support its healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Supplemental Agreement for work within scope | ($2k) | 9/20/18 | |
| Not listed | Not listed | $98.6k | 9/10/15 |